About CAR-T
-
CAR-T therapy for adult leukemia
The GoBroad medical team is among the first in China to carry out immunotherapy,partnering with enterprises to pioneer the use of novel second-generation CD19-41BB-CAR-T cell therapy for treating refr…
-
CAR-T Therapy for Adult Lymphoma and Multiple Myeloma
After five years of unremitting efforts,the adult lymphoma team has caught the first wave of the era from chemotherapy to targeted and cellular immunotherapy.Based on current technologies and advantag…
-
CAR-T Treatment for Pediatric Lymphoma
Under the leadership of Professor Zhang Yonghong,who has worked in pediatric hematologic oncology for over 30 years,the Pediatric Lymphoma Department was established in 2017 at Beijing GoBroad Boren H…
-
The Pediatric Hematologic Oncology Immunotherapy Team
Facing clinical challenges,continuously deepening CAR-T treatment for T-cell tumors:1.Autologous CD7 CAR-T for R/R T-ALL/LBL:One month after CAR-T infusion,the complete remission(CR)rate with MRD nega…
